Inspection Record

Quantipharm Inc. — Health Canada Inspection Findings

Health CanadaInspected 2023-05-23 5 findingsEquipment and facilityOther quality systemDeviation, CAPA, and investigationComputer system validation

View the regulator's official source The source document is always the basis for judgement.

Findings

1Equipment and facility

The establishment and/or the maintenance of a data governance plan was inadequate.

2Other quality system

The recorded information or details were inadequate. The receipt, preparation, and/or handling of reagents and culture media was inadequate.

3Deviation, CAPA, and investigation

Investigations into deviations, reports, and/or follow-up actions were inadequate.

4Deviation, CAPA, and investigation

The investigation, handling, and/or reporting of test results that were out-of-specification was inadequate.

5Computer system validation

The calibration, inspection, and/or qualification of the equipment, including computerized systems, was inadequate.

About this record

Extracted automatically from the document of the Health Canada inspection on 2023-05-23. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Quantipharm Inc. company profile — full history Health Canada documents, 2023 Go to Findings search